Citius Oncology (CTOR) Stock Insights
CTOR$0.61+0.00 +0.05%
$56.84M
Market Cap
—
P/E
—
Forward P/E
—
Score
Citius Oncology (CTOR) Stock Insights
CTOR price $0.61 +0.00 +0.05%
- Ticker
- CTOR
- Price
- $0.61
- Change
- +0.00 +0.05%
- Market cap ?
- $56.84M
- Beta ?
- 3.40
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
Fair value
CTOR fair value $3.91. Price $0.61. Price is 84% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-12-17 | — | -0.07 | — | 3.29M |
| 2026-08-14 | -0.08 | -0.07 | 1.49M | 2.50M |
| 2026-05-15 | -0.27 | -0.01 | 1.67M | 7.00M |
| 2026-02-13 | -0.06 | -0.04 | 3.94M | 4.37M |
| 2025-12-23 | -0.06 | -0.06 | — | — |
| 2025-08-12 | -0.08 | -0.15 | — | — |
| 2025-05-14 | -0.11 | -0.09 | — | 5.74M |
| 2025-02-14 | -0.09 | -0.06 | — | — |
| 2024-12-27 | -0.07 | -0.08 | — | — |
| 2024-03-31 | 0.01 | — | — | — |
| 2023-12-31 | -0.05 | — | — | — |
| 2023-09-30 | 0.00 | — | — | — |
| 2023-06-30 | 0.07 | — | — | — |
| 2023-03-31 | 0.07 | — | — | — |
| 2022-12-31 | 0.04 | — | — | — |
| 2022-09-30 | -0.00 | — | — | — |
| 2022-06-30 | -0.00 | — | — | — |
| 2021-04-30 | -0.00 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Peri Jonathan | Other | 0 | — | — |
| 2025-09-19 | HOLUBIAK MYRON Z | Buy | 850.00K | — | — |
| 2025-09-19 | HOLUBIAK MYRON Z | Buy | 100.00K | — | — |
| 2025-09-19 | Smith Robert Joseph | Buy | 300.00K | — | — |
| 2025-09-19 | Mazur Leonard L | Buy | 1.70M | — | — |
| 2025-09-19 | Webb Carol | Buy | 300.00K | — | — |
| 2025-09-19 | Czuczman Myron | Buy | 825.00K | — | — |
| 2025-09-19 | MCGRATH DENNIS M | Buy | 300.00K | — | — |
| 2025-09-19 | Bartushak Jaime | Buy | 825.00K | — | — |
| 2025-09-19 | Mayersohn Joel David | Buy | 300.00K | — | — |
| 2025-09-19 | Dutia Suren G | Buy | 300.00K | — | — |
| 2025-09-19 | Holuka Eugene Myron | Buy | 300.00K | — | — |
| 2025-07-28 | Mayersohn Joel David | Buy | 21.23K | — | — |
| 2024-12-12 | Mayersohn Joel David | Buy | 250.00K | $1.07 | 267.50K |
| 2024-12-12 | Holuka Eugene Myron | Buy | 125.00K | $1.07 | 133.75K |
| 2024-12-12 | HOLUBIAK MYRON Z | Buy | 300.00K | $1.07 | 321.00K |
| 2024-12-12 | HOLUBIAK MYRON Z | Buy | 50.00K | $1.07 | 53.50K |
| 2024-12-12 | Smith Robert Joseph | Buy | 125.00K | $1.07 | 133.75K |
| 2024-12-12 | Webb Carol | Buy | 125.00K | $1.07 | 133.75K |
| 2024-12-12 | Dutia Suren G | Buy | 125.00K | $1.07 | 133.75K |
| 2024-12-12 | MCGRATH DENNIS M | Buy | 125.00K | $1.07 | 133.75K |
| 2024-12-12 | Bartushak Jaime | Buy | 400.00K | $1.07 | 428.00K |
| 2024-12-12 | Mazur Leonard L | Buy | 800.00K | $1.07 | 856.00K |
| 2024-12-12 | Czuczman Myron | Buy | 400.00K | $1.07 | 428.00K |
| 2024-08-12 | Mazur Leonard L | Buy | 3.70M | $2.15 | 7.96M |
| 2024-08-12 | HOLUBIAK MYRON Z | Buy | 1.50M | $2.15 | 3.23M |
| 2024-08-12 | Czuczman Myron | Buy | 1.40M | $2.15 | 3.01M |
| 2024-08-12 | Bartushak Jaime | Buy | 1.40M | $2.15 | 3.01M |
| 2024-08-12 | Holuka Eugene Myron | Buy | 150.00K | $2.15 | 322.50K |
| 2024-08-12 | Holuka Eugene Myron | Other | 0 | — | — |
| 2024-08-12 | Dutia Suren G | Buy | 150.00K | $2.15 | 322.50K |
| 2024-08-12 | HOLUBIAK MYRON Z | Buy | 500.00K | $2.15 | 1.07M |
| 2024-08-12 | Czuczman Myron | Buy | 466.67K | $2.15 | 1.00M |
| 2024-08-12 | Mazur Leonard L | Buy | 1.23M | $2.15 | 2.65M |
| 2024-08-12 | Bartushak Jaime | Buy | 466.67K | $2.15 | 1.00M |
| 2024-08-12 | MCGRATH DENNIS M | Buy | 150.00K | $2.15 | 322.50K |
| 2024-08-12 | Citius Pharmaceuticals, Inc. | Other | 0 | — | — |
| 2024-08-12 | Webb Carol | Buy | 150.00K | $2.15 | 322.50K |
| 2024-08-12 | Dutia Suren G | Other | 0 | — | — |
| 2024-08-12 | Smith Robert Joseph | Other | 0 | — | — |
| 2024-08-12 | HOLUBIAK MYRON Z | Other | 0 | — | — |
| 2024-08-12 | Czuczman Myron | Other | 0 | — | — |
| 2024-08-12 | Mazur Leonard L | Other | 0 | — | — |
| 2024-08-12 | Bartushak Jaime | Other | 0 | — | — |
| 2024-08-12 | MCGRATH DENNIS M | Other | 0 | — | — |
| 2024-08-12 | Citius Pharmaceuticals, Inc. | Sell | 0 | — | — |
| 2024-08-12 | Webb Carol | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 20, holders +7 vs prior quarter. Ownership 13.11%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 8.71M | -483.27K | -5.26% | 5.66M |
| BANK OF AMERICA CORP /DE/ | 3.84M | 0 | 0.00% | 2.49M |
| VANGUARD CAPITAL MANAGEMENT LLC | 546.33K | 11.50K | +2.15% | 355.11K |
| UBS GROUP AG | 334.62K | 297.78K | +808.30% | 217.50K |
| GEODE CAPITAL MANAGEMENT, LLC | 245.41K | -19.33K | -7.30% | 159.54K |
| VANGUARD FIDUCIARY TRUST CO | 121.91K | 0 | 0.00% | 79.24K |
| IFP ADVISORS, INC | 107.42K | 0 | 0.00% | 69.84K |
| CITADEL ADVISORS LLC | 90.59K | 90.59K | New | 58.89K |
| NORTHERN TRUST CORP | 45.75K | 0 | 0.00% | 29.74K |
| STATE STREET CORP | 42.90K | 0 | 0.00% | 27.89K |
| VIRTU FINANCIAL LLC | 21.88K | 21.88K | New | 14.00K |
| XTX TOPCO LTD | 20.64K | 20.64K | New | 13.42K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 13.82K | 13.82K | New | 8.98K |
| ARKADIOS WEALTH ADVISORS | 11.67K | 0 | 0.00% | 7.58K |
| OSAIC HOLDINGS, INC. | 1.00K | -9.12K | -90.12% | 650 |
| WELLS FARGO & COMPANY/MN | 500 | 500 | New | 325 |
| MERCER GLOBAL ADVISORS INC /ADV | 200 | 200 | New | 130 |
| BARCLAYS PLC | 90 | 90 | New | 59 |
| MORGAN STANLEY | 23 | 23 | New | 15 |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 1 | 0 | 0.00% | 1 |
| BLACKROCK, INC. | 0 | -47.45K | -100.00% | 0 |
Insights · Dividends · Forecast · Financials · Learn